Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:didanosine
|
| gptkbp:approvedBy |
1991
|
| gptkbp:ATCCode |
J05AF02
|
| gptkbp:contraindication |
history of pancreatitis
allergy to didanosine |
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:form |
enteric-coated capsule
|
| gptkbp:halfLife |
1.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Videx EC
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:pregnancyCategory |
B
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
pancreatitis
peripheral neuropathy hepatomegaly lactic acidosis |
| gptkbp:storage |
store at room temperature
|
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:didanosine
|
| gptkbp:bfsLayer |
6
|